InvestorsHub Logo
Followers 11
Posts 344
Boards Moderated 0
Alias Born 02/01/2011

Re: None

Wednesday, 09/09/2020 6:38:11 AM

Wednesday, September 09, 2020 6:38:11 AM

Post# of 44690
Here is a report submitted for peer review on another medication that in combination with RLF100 might have had a deciding factor for CaptainTommy's survival as it'S MoA targets systemic inflammation:
https://www.cureus.com/articles/39133-icosapent-ethyl---a-successful-treatment-for-symptomatic-covid-19-infection
As VASCEPA is used to reduce the risk of heart attacks ad cardiovascular events in combination with RLF100's properties to actually destroy the virus virus it might have led to a positive a outcome..
That is certainly something to consider in terms of combo patents